Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Interv. 2007 Jun;7(3):147-56.

Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues.

Author information

1
Graduate Center for Toxicology and Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA.

Abstract

Injury to nontargeted tissues in chemotherapy often complicates cancer treatment by limiting therapeutic dosages of anticancer drugs and by impairing the quality of life of patients during and after treatment. Oxidative stress, directly or indirectly caused by chemotherapeutics as exemplified by doxorubicin, is one of the underlying mechanisms of the toxicity of anticancer drugs in noncancerous tissues, including the heart and brain. A comprehensive understanding of the mechanisms of oxidative injury to normal tissue will be essential for the improvement of strategies to prevent or attenuate the toxicity of chemotherapeutic agents without compromising their chemotherapeutic value.

PMID:
17609521
DOI:
10.1124/mi.7.3.6
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center